Evidence that variation at the serotonin transporter gene influences susceptibility to attention deficit hyperactivity disorder (ADHD)

Analysis and pooled analysis

L. Kent, U. Doerry, E. Hardy, R. Parmar, K. Gingell, Z. Hawi, A. Kirley, N. Lowe, M Fitzgerald, M. Gill, N. Craddock

Research output: Contribution to journalArticleResearchpeer-review

124 Citations (Scopus)

Abstract

Reduced central serotonergic activity has been implicated in poor impulse regulation and aggressive behaviour in animals, adults and also young children. Two recently published studies have implicated variation at a polymorphism in the promoter of the serotonin transporter (5HTT; hSERT) in influencing susceptibility to ADHD. Consistent with these results we have also found a trend for the long allele of the promoter polymorphism to influence susceptibility to ADHD in a sample of 113 ADHD parent proband trios (65 transmissions vs 49 non-transmissions, χ2 = 2.25, P = 0.13). A pooled analysis of our, and these published results demonstrated a significant over representation of the long allele of the promoter in ADHD probands compared to controls (χ2 = 7.14, P = 0.008). We have also examined two other 5HTT polymorphisms (the VNTR in intron 2 and the 3′ UTR SNP). TDT analysis demonstrated preferential transmission of the T allele of the 3′ UTR SNP (χ2 = 4.06, P = 0.04). In addition, ETDT analysis of haplotypes demonstrated significant preferential transmission of haplotypes containing the T allele of the 3′ UTR SNP with the long allele of the promoter polymorphism (χ2 = 13.18, 3 df, P = 0.004) and the 10 repeat of the VNTR (χ2 = 8.77, 3 df, P = 0.03). This study provides further evidence for the possible involvement of the serotonin transporter in susceptibility to ADHD.
Original languageEnglish
Pages (from-to)908-912
Number of pages5
JournalMolecular Psychiatry
Volume7
Issue number8
DOIs
Publication statusPublished - 2002
Externally publishedYes

Keywords

  • 5HTT
  • ADHD
  • Association study
  • HSERT

Cite this

Kent, L. ; Doerry, U. ; Hardy, E. ; Parmar, R. ; Gingell, K. ; Hawi, Z. ; Kirley, A. ; Lowe, N. ; Fitzgerald, M ; Gill, M. ; Craddock, N. / Evidence that variation at the serotonin transporter gene influences susceptibility to attention deficit hyperactivity disorder (ADHD) : Analysis and pooled analysis. In: Molecular Psychiatry. 2002 ; Vol. 7, No. 8. pp. 908-912.
@article{2bc5bc38350c445faea24b68afcaf822,
title = "Evidence that variation at the serotonin transporter gene influences susceptibility to attention deficit hyperactivity disorder (ADHD): Analysis and pooled analysis",
abstract = "Reduced central serotonergic activity has been implicated in poor impulse regulation and aggressive behaviour in animals, adults and also young children. Two recently published studies have implicated variation at a polymorphism in the promoter of the serotonin transporter (5HTT; hSERT) in influencing susceptibility to ADHD. Consistent with these results we have also found a trend for the long allele of the promoter polymorphism to influence susceptibility to ADHD in a sample of 113 ADHD parent proband trios (65 transmissions vs 49 non-transmissions, χ2 = 2.25, P = 0.13). A pooled analysis of our, and these published results demonstrated a significant over representation of the long allele of the promoter in ADHD probands compared to controls (χ2 = 7.14, P = 0.008). We have also examined two other 5HTT polymorphisms (the VNTR in intron 2 and the 3′ UTR SNP). TDT analysis demonstrated preferential transmission of the T allele of the 3′ UTR SNP (χ2 = 4.06, P = 0.04). In addition, ETDT analysis of haplotypes demonstrated significant preferential transmission of haplotypes containing the T allele of the 3′ UTR SNP with the long allele of the promoter polymorphism (χ2 = 13.18, 3 df, P = 0.004) and the 10 repeat of the VNTR (χ2 = 8.77, 3 df, P = 0.03). This study provides further evidence for the possible involvement of the serotonin transporter in susceptibility to ADHD.",
keywords = "5HTT, ADHD, Association study, HSERT",
author = "L. Kent and U. Doerry and E. Hardy and R. Parmar and K. Gingell and Z. Hawi and A. Kirley and N. Lowe and M Fitzgerald and M. Gill and N. Craddock",
year = "2002",
doi = "10.1038/sj.mp.4001100",
language = "English",
volume = "7",
pages = "908--912",
journal = "Molecular Psychiatry",
issn = "1359-4184",
publisher = "Nature Publishing Group",
number = "8",

}

Evidence that variation at the serotonin transporter gene influences susceptibility to attention deficit hyperactivity disorder (ADHD) : Analysis and pooled analysis. / Kent, L.; Doerry, U.; Hardy, E.; Parmar, R.; Gingell, K.; Hawi, Z.; Kirley, A.; Lowe, N.; Fitzgerald, M; Gill, M.; Craddock, N.

In: Molecular Psychiatry, Vol. 7, No. 8, 2002, p. 908-912.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Evidence that variation at the serotonin transporter gene influences susceptibility to attention deficit hyperactivity disorder (ADHD)

T2 - Analysis and pooled analysis

AU - Kent, L.

AU - Doerry, U.

AU - Hardy, E.

AU - Parmar, R.

AU - Gingell, K.

AU - Hawi, Z.

AU - Kirley, A.

AU - Lowe, N.

AU - Fitzgerald, M

AU - Gill, M.

AU - Craddock, N.

PY - 2002

Y1 - 2002

N2 - Reduced central serotonergic activity has been implicated in poor impulse regulation and aggressive behaviour in animals, adults and also young children. Two recently published studies have implicated variation at a polymorphism in the promoter of the serotonin transporter (5HTT; hSERT) in influencing susceptibility to ADHD. Consistent with these results we have also found a trend for the long allele of the promoter polymorphism to influence susceptibility to ADHD in a sample of 113 ADHD parent proband trios (65 transmissions vs 49 non-transmissions, χ2 = 2.25, P = 0.13). A pooled analysis of our, and these published results demonstrated a significant over representation of the long allele of the promoter in ADHD probands compared to controls (χ2 = 7.14, P = 0.008). We have also examined two other 5HTT polymorphisms (the VNTR in intron 2 and the 3′ UTR SNP). TDT analysis demonstrated preferential transmission of the T allele of the 3′ UTR SNP (χ2 = 4.06, P = 0.04). In addition, ETDT analysis of haplotypes demonstrated significant preferential transmission of haplotypes containing the T allele of the 3′ UTR SNP with the long allele of the promoter polymorphism (χ2 = 13.18, 3 df, P = 0.004) and the 10 repeat of the VNTR (χ2 = 8.77, 3 df, P = 0.03). This study provides further evidence for the possible involvement of the serotonin transporter in susceptibility to ADHD.

AB - Reduced central serotonergic activity has been implicated in poor impulse regulation and aggressive behaviour in animals, adults and also young children. Two recently published studies have implicated variation at a polymorphism in the promoter of the serotonin transporter (5HTT; hSERT) in influencing susceptibility to ADHD. Consistent with these results we have also found a trend for the long allele of the promoter polymorphism to influence susceptibility to ADHD in a sample of 113 ADHD parent proband trios (65 transmissions vs 49 non-transmissions, χ2 = 2.25, P = 0.13). A pooled analysis of our, and these published results demonstrated a significant over representation of the long allele of the promoter in ADHD probands compared to controls (χ2 = 7.14, P = 0.008). We have also examined two other 5HTT polymorphisms (the VNTR in intron 2 and the 3′ UTR SNP). TDT analysis demonstrated preferential transmission of the T allele of the 3′ UTR SNP (χ2 = 4.06, P = 0.04). In addition, ETDT analysis of haplotypes demonstrated significant preferential transmission of haplotypes containing the T allele of the 3′ UTR SNP with the long allele of the promoter polymorphism (χ2 = 13.18, 3 df, P = 0.004) and the 10 repeat of the VNTR (χ2 = 8.77, 3 df, P = 0.03). This study provides further evidence for the possible involvement of the serotonin transporter in susceptibility to ADHD.

KW - 5HTT

KW - ADHD

KW - Association study

KW - HSERT

UR - http://www.scopus.com/inward/record.url?scp=0036384203&partnerID=8YFLogxK

U2 - 10.1038/sj.mp.4001100

DO - 10.1038/sj.mp.4001100

M3 - Article

VL - 7

SP - 908

EP - 912

JO - Molecular Psychiatry

JF - Molecular Psychiatry

SN - 1359-4184

IS - 8

ER -